| |
| |
|
| Insider
Information: |
Ivers-Read Gillian C |
| Relationship: |
See Remarks |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
293,612 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,404 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
293,612 |
|
|
| Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
27
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
24
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1,222.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WTKND |
Welltek Incorporated |
EVP, Development Operations |
• – – |
2007-12-06 |
4 |
D |
$63.98 |
$13,884 |
D/D |
(217) |
43,472 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-12-04 |
4 |
S |
$21.23 |
$5,308 |
D/D |
(250) |
186,152 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-06-06 |
4 |
D |
$47.70 |
$13,261 |
D/D |
(278) |
183,342 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-09-05 |
4 |
D |
$35.75 |
$10,082 |
D/D |
(282) |
184,731 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-06-03 |
4 |
S |
$5.63 |
$1,593 |
D/D |
(283) |
249,905 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-09-02 |
4 |
S |
$4.89 |
$1,487 |
D/D |
(304) |
254,980 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-12-02 |
4 |
S |
$3.00 |
$912 |
D/D |
(304) |
260,041 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-09-03 |
4 |
S |
$5.30 |
$2,931 |
D/D |
(553) |
211,694 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-06-04 |
4 |
S |
$15.07 |
$8,695 |
D/D |
(577) |
190,742 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-03-02 |
4 |
S |
$6.29 |
$3,648 |
D/D |
(580) |
245,079 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-12-03 |
4 |
S |
$4.89 |
$2,841 |
D/D |
(581) |
215,522 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-12-03 |
4 |
S |
$14.59 |
$8,640 |
D/D |
(592) |
194,229 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
S |
$7.03 |
$4,204 |
D/D |
(598) |
207,809 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-03-03 |
4 |
S |
$7.20 |
$4,356 |
D/D |
(605) |
203,775 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
183,620 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
185,013 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-12-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
186,402 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-09-04 |
4 |
S |
$5.21 |
$3,282 |
D/D |
(630) |
192,471 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
EVP, Development Operations |
• – – |
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(653) |
46,040 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
687 |
250,188 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
687 |
260,345 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
688 |
255,284 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
EVP, Development Operations |
• – – |
2007-12-06 |
4 |
OE |
$63.98 |
$44,786 |
D/D |
700 |
43,689 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-03-20 |
4 |
D |
$56.75 |
$47,046 |
D/D |
(829) |
182,995 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-06-20 |
4 |
D |
$45.75 |
$37,927 |
D/D |
(829) |
184,388 |
0 |
- |
|
117 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
